NovaBay Pharmaceuticals (NBY) Raw Materials (2016 - 2024)
Historic Raw Materials for NovaBay Pharmaceuticals (NBY) over the last 12 years, with Q4 2024 value amounting to $127000.0.
- NovaBay Pharmaceuticals' Raw Materials fell 8653.23% to $127000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $127000.0, marking a year-over-year decrease of 8653.23%. This contributed to the annual value of $127000.0 for FY2024, which is 8653.23% down from last year.
- Per NovaBay Pharmaceuticals' latest filing, its Raw Materials stood at $127000.0 for Q4 2024, which was down 8653.23% from $160000.0 recorded in Q1 2024.
- Over the past 5 years, NovaBay Pharmaceuticals' Raw Materials peaked at $1.3 million during Q2 2022, and registered a low of $127000.0 during Q4 2024.
- Over the past 5 years, NovaBay Pharmaceuticals' median Raw Materials value was $618500.0 (recorded in 2021), while the average stood at $671277.8.
- Per our database at Business Quant, NovaBay Pharmaceuticals' Raw Materials skyrocketed by 64150.94% in 2021 and then crashed by 8653.23% in 2024.
- Quarter analysis of 5 years shows NovaBay Pharmaceuticals' Raw Materials stood at $159000.0 in 2020, then skyrocketed by 641.51% to $1.2 million in 2021, then increased by 7.97% to $1.3 million in 2022, then fell by 25.92% to $943000.0 in 2023, then tumbled by 86.53% to $127000.0 in 2024.
- Its Raw Materials was $127000.0 in Q4 2024, compared to $160000.0 in Q1 2024 and $943000.0 in Q4 2023.